PLAY PODCASTS
Key HIV Studies Influencing My Practice Following IDWeek and HIV Glasgow 2022—Audio Recap
Episode 223

Key HIV Studies Influencing My Practice Following IDWeek and HIV Glasgow 2022—Audio Recap

Listen to expert insights from Chloe Orkin, MBChB, FRCP, MD, and Babafemi Taiwo, MBBS, on some of the most clinically relevant new HIV data presented at IDWeek and HIV Glasgow 2022, including prevention strategies, long-acting therapies, and investigational agents.

Decera Clinical Education Infectious Disease Podcast · Chloe Orkin MBChB FRCP MD, Babafemi Taiwo MBBS

December 5, 202238m 29s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode,  Chloe Orkin, MBChB, FRCP, MD, and Babafemi Taiwo, MBBS, discuss new HIV data presented at IDWeek and HIV Glasgow 2022, including

  • Prevention strategies
  • LA therapies
  • Investigational agents

Presenters:

Chloe Orkin, MBChB, FRCP, MD
Professor of HIV
Queen Mary, University of London
Consultant Physician
Lead for HIV Research
Barts Health NHS Trust
The Royal London Hospital
London, United Kingdom

Babafemi Taiwo, MBBS
Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University 
Feinberg School of Medicine
Chicago, Illinois

Content based on an online CME/CE program supported by an independent educational grant from Gilead Sciences, Inc.; 
Janssen Therapeutics, Division of Janssen Products, LP; and ViiV Healthcare. 

Link to full program:
https://bit.ly/3iFEF0T


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

islatraviropera cohortcabotegravircabotegravir plus rilpivirinelong-acting injectable hiv treatmentla artheavily treatment-experienced hivchloe orkinlenacapavirhiv preventionhiv prepcarisel studyla hiv treatmenthiv womencarlos studylong-acting hiv treatmentbabafemi taiwocab plus rpv implementationhiv treatmentcapella